Chris Rigg - Elevance Health SVP Division
| ELV Stock | USD 345.74 1.24 0.36% |
VP
Chris Rigg is SVP Division of Elevance Health
| Address | 220 Virginia Avenue, Indianapolis, IN, United States, 46204 |
| Phone | 833 401 1577 |
| Web | https://www.elevancehealth.com |
Elevance Health Management Efficiency
The company has Return on Asset of 0.0437 % which means that on every $100 spent on assets, it made $0.0437 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1325 %, implying that it generated $0.1325 on every 100 dollars invested. Elevance Health's management efficiency ratios could be used to measure how well Elevance Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.06 in 2026. Return On Capital Employed is likely to drop to 0.08 in 2026. At this time, Elevance Health's Non Currrent Assets Other are fairly stable compared to the past year. Other Assets is likely to climb to about 141.1 B in 2026, whereas Non Current Assets Total are likely to drop slightly above 35.9 B in 2026.Similar Executives
| Showing other executives | VP Age | ||
| Joseph Ruschell | Humana Inc | N/A | |
| Katerina Guerraz | CVS Health Corp | N/A | |
| Joseph JD | Regeneron Pharmaceuticals | 67 | |
| Robert Giglietti | GE HealthCare Technologies | N/A | |
| Nick Stone | GlaxoSmithKline PLC ADR | N/A | |
| Claudia Curtis | Becton Dickinson and | N/A | |
| Adam Reiffe | Becton Dickinson and | N/A | |
| J Quinn | Cencora | N/A | |
| Kourosh JD | Cencora | N/A | |
| Sharon JD | IDEXX Laboratories | 65 | |
| Michael Feld | Becton Dickinson and | 46 | |
| Julie Fuller | Zoetis Inc | 54 | |
| Jeffrey Carr | IDEXX Laboratories | N/A | |
| Amit Gupta | IDEXX Laboratories | N/A | |
| Lazarus Krikorian | Cencora | 61 | |
| Pamela Spikner | Becton Dickinson and | 49 | |
| Samrat Esq | CVS Health Corp | 59 | |
| Nicole JD | Cigna Corp | 55 | |
| FACEP MD | CVS Health Corp | N/A | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0437 |
Elevance Health Leadership Team
Elected by the shareholders, the Elevance Health's board of directors comprises two types of representatives: Elevance Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elevance. The board's role is to monitor Elevance Health's management team and ensure that shareholders' interests are well served. Elevance Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elevance Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chris Rigg, SVP Division | ||
| Ronald Penczek, Controller VP | ||
| Erin Wessling, EVP Officer | ||
| Scott Anglin, Treasurer SVP | ||
| John Gallina, Ex CFO | ||
| Shantanu MD, Chief Officer | ||
| Julie Goon, Senior Affairs | ||
| Felicia Norwood, Executive Benefits | ||
| Charles Kendrick, Executive Benefits | ||
| Blair Todt, Executive Officer | ||
| Udi Manber, Chief Officer | ||
| Stephen CFA, Vice Relations | ||
| Gloria McCarthy, Exec Officer | ||
| Kyle Weber, Chief Officer | ||
| Nathan Rich, Vice Relations | ||
| Peter Esq, Executive CarelonRx | ||
| Scott Towers, President Business | ||
| Beth Chesmha, President Indiana | ||
| Paul Marchetti, President CarelonRx | ||
| Gail Boudreaux, CEO President | ||
| Anil Bhatt, Chief Officer | ||
| Mark Kaye, Executive CFO |
Elevance Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Elevance Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0437 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 99.67 B | ||||
| Shares Outstanding | 222.24 M | ||||
| Shares Owned By Insiders | 0.16 % | ||||
| Shares Owned By Institutions | 91.81 % | ||||
| Number Of Shares Shorted | 3.69 M | ||||
| Price To Earning | 19.27 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Elevance Stock Analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.